October 21, 2015

No Image

New York Mets Beat The Cubs To Win National League Title

New York Mets' Daniel Murphy rounds first after hitting a two-run homer in the eighth inning of Game 4 of the National League championship series against the Chicago Cubs.

New York Mets’ Daniel Murphy rounds first after hitting a two-run homer in the eighth inning of Game 4 of the National League championship series against the Chicago Cubs. David J. Phillip/AP hide caption

itoggle caption David J. Phillip/AP

The New York Mets are headed to the World Series for the first time since 2000. Fired by a record-breaking home-run drive by Daniel Murphy, the Mets completed a four-game sweep of the Chicago Cubs for the National League Championship.

Wednesday’s 8-3 loss for the Cubs crushed the sell-out crowd at Chicago’s Wrigley Field.

With a two-run drive in the eighth inning, Murphy homered in his sixth consecutive game, and added a double and two singles for good measure.

The second baseman has homered in back-to-back games only once before in his six-year career, according to the Associated Press.

The Mets will face either the Toronto Blue Jays or the Kansas City Royals in the World Series. The Blue Jays beat Kansas in Game 5 of the American League series in Toronto earlier Wednesday, forcing a Game 6 in Kansas City with the Royals ahead 3-2.

This entry passed through the Full-Text RSS service – if this is your content and you’re reading it on someone else’s site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.


No Image

As Valeant's Troubles Mount, Its Stock Price Takes Another Dive

Now, that’s a lousy day in the market.

Valeant Pharmaceuticals, already under fire for its drug-pricing policies, was accused on Wednesday of creating phantom sales to falsely inflate revenues.

The allegations were made by Citron Research, a short-selling firm, in a report entitled, “Could this be the Pharmaceutical Enron?”

Short-sellers such as Citron make bets that a company’s stock will fall and they benefit when the price goes down, so their opinions can often be viewed with skepticism.

Nevertheless, the report sent Valeant’s stock, a favorite of hedge funds, plummeting by as much as 41 percent, eliminating as much as $20 billion from its market value. The stock is now down about 54 percent from its August high.

Multi-billionaire investor Bill Ackman of Pershing Square Capital Management was said to have lost as much as $2 billion on the stock, although with the price now so low, Ackman also told CNBC he is loading up on new shares.

Valeant, based in Quebec, is reportedly under investigation by federal prosecutors, who are seeking information about its pricing and distribution policies. The company has purchased the rights to sell two heart drugs, Nitopress and Isuprel, and raised their prices by 212 and 525 percent, respectively.

Such practices have been especially controversial lately after Turing Pharmaceuticals bought the right to sell Duraprim and then raised its price by 5,000 percent. After that huge increase was widely denounced as price-gouging, Turing agreed to lower the price.

Valeant’s troubles mounted Wednesday after the release of Citron’s report, which said the company used its relationship with specialty pharmaceutical companies such as Philidor to create phantom sales that made revenue look higher than it was.

Valeant issued a statement calling the report erroneous and denying any attempt to inflate revenue.

“There is no sales benefit from any inventory held at these specialty pharmacies,” Valeant said, in the statement.

Earlier this week, the New York Times reported that Valeant and other drug companies were using mail-order specialty firms to circumvent efforts by insurance companies to switch patients to cheaper, generic versions of their drugs.

This entry passed through the Full-Text RSS service – if this is your content and you’re reading it on someone else’s site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.


No Image

What To Do With California's Mentally Ill Defendants?

Mentally ill prisoners too impaired to stand trial are supposed to be transferred to state mental hospitals for treatment within two or three months. But more than 300 in California are languishing in county jails because hospitals don't have the beds.

Mentally ill prisoners too impaired to stand trial are supposed to be transferred to state mental hospitals for treatment within two or three months. But more than 300 in California are languishing in county jails because hospitals don’t have the beds. Christian Schmidt/Corbis hide caption

itoggle caption Christian Schmidt/Corbis

In 2010, Rodney Bock was arrested for carrying a loaded gun into a restaurant in Yuba City, Calif., north of Sacramento. Bock had severe mental illness and was later found incompetent to stand trial. He was released on bail, but was rearrested after he failed to appear at a court hearing.

Bock, 56, was placed in the Sutter County jail, awaiting transfer to a state hospital. While there, he began suffering hallucinations. After more than two weeks in jail, Bock hanged himself.

Mentally ill defendants like Bock, who are declared incompetent to stand trial, are supposed to be transferred to state mental hospitals for treatment within two or three months. But more than 300 of them throughout California are languishing in county jails because there’s simply no bed space.

Bock’s daughters are now plaintiffs in a lawsuit filed by the American Civil Liberties Union, charging two state agencies, including the Department of State Hospitals, with denying mentally ill inmates their right to due process — and the treatment they need.

“Jail is simply too dangerous a place for these most vulnerable defendants,” said Micaela Davis, lead attorney in the lawsuit. “We have inmates that are waiting eight, nine months and sometimes over a year before being transferred to a facility for treatment.”

California’s new state budget includes more than $17 million to add beds for defendants declared incompetent to stand trial. But not everyone agrees that’s the best approach.

Stephen Manley is a mental health court judge in Santa Clara County. His court helps defendants struggling with severe mental illnesses, including bipolar disorder or schizophrenia, find alternatives to incarceration.

Manley doesn’t want more psychiatric hospital beds; he wants to reserve state hospitals for the most violent defendants.

We send far too many people to state hospitals who do not pose a risk to public safety,” he says, “because we don’t work with them to figure out if there isn’t a local alternative.”

Manley believes the psychiatric hospitals are already overcrowded — and understaffed. “As long as we keep overcrowding the hospitals, all we do is feed the fire,” he says, referring to violence within the hospitals.

Last year alone, there were more than 1,800 physical assaults at Napa State Hospital, a psychiatric institution in the heart of Northern California’s wine country. More than 80 percent of the patients there have been referred by the criminal justice system, and hospital officials say patients who are there to have their sanity restored for trial inflict the most serious injuries.

Ryan Navarre, with the organization representing Napa Hospital police, says that even officers are at risk. He recalls one patient specifically who put rocks into his socks and then spun them around “violently,” he says.

Throughout California, state psychiatric hospitals are working to find a balance between treatment and security for patients and staff.

Meanwhile, Manley thinks the best solution for nonviolent offenders is to create more community-based treatment facilities.

“If we add another 500 beds – and people — to a state hospital, all we do is make the problem worse,” he says.

But funding is already inadequate for mental health treatment. And creating more community-based programs raises new challenges — including resistance from neighbors who don’t really want to live near facilities whose clients are mentally ill criminal defendants.

This post was produced by KQED’s State of Health blog.

This entry passed through the Full-Text RSS service – if this is your content and you’re reading it on someone else’s site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.


No Image

Songs We Love: Buika Feat. Jason Mraz, 'Carry Your Own Weight'

Buika's new album, Vivir Sin Miedo, is available now.
4:11

Buika’s new album, Vivir Sin Miedo, is available now. JaviRojo/Courtesy of the artist hide caption

itoggle caption JaviRojo/Courtesy of the artist

Maria Concepción Balboa Buika, the vocalist known simply as Buika has an extraordinary voice. It’s based in flamenco, which she heard as a child on the Spanish island of Mallorca. But layered on top of that are a whole range of popular influences including jazz and R&B (she was once a Tina Turner impersonator in Las Vegas).

Buika has been gathering up new fans with every release since her first internationally released album in 2005. The album she dedicated to Mexican ranchera singer Chavela Vargas (2009’s El Último Trago, recorded with the Cuban pianist, Chucho Valdés) was a high-water mark, a mix of artistic interpretation and unbridled passion that almost made her a star. Yet after hearing her newest album Vivir Sin Miedo, I don’t think stardom is what is on her mind: she is obviously far more concerned about using her voice to explore an ever-expanding range of genres and styles.

The album features instrumentation that I would more expect from a singer like Cassandra Wilson, with Buika’s voice now floating amidst shimmering electric guitars and bluesy organ swirls. She is singing flawlessly in English, and of course there are now hints of hip-hop, not unexpected since she is of a generation that grew up with the music.

[embedded content]
YouTube

As “Carry Your Own Weight” make clear, Buika has also attracted some high profile admirers — in this case, Jason Mraz. Check out the video, then download the album and welcome to the amazing world of music that is Buika.

Vivir Sin Miedo is out now on Warner Music Latina.

This entry passed through the Full-Text RSS service – if this is your content and you’re reading it on someone else’s site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.